Cargando…

The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants

Engineering of amyloid structures is one of the new perspective areas of protein engineering. Studying the process of amyloid formation can help find ways to manage it in the interests of medicine and biotechnology. One of the promising candidates for the structural basis of artificial functional am...

Descripción completa

Detalles Bibliográficos
Autores principales: Balobanov, Vitalii, Chertkova, Rita, Egorova, Anna, Dolgikh, Dmitry, Bychkova, Valentina, Kirpichnikov, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072675/
https://www.ncbi.nlm.nih.gov/pubmed/32033353
http://dx.doi.org/10.3390/biom10020241
_version_ 1783506461742071808
author Balobanov, Vitalii
Chertkova, Rita
Egorova, Anna
Dolgikh, Dmitry
Bychkova, Valentina
Kirpichnikov, Mikhail
author_facet Balobanov, Vitalii
Chertkova, Rita
Egorova, Anna
Dolgikh, Dmitry
Bychkova, Valentina
Kirpichnikov, Mikhail
author_sort Balobanov, Vitalii
collection PubMed
description Engineering of amyloid structures is one of the new perspective areas of protein engineering. Studying the process of amyloid formation can help find ways to manage it in the interests of medicine and biotechnology. One of the promising candidates for the structural basis of artificial functional amyloid fibrils is albebetin (ABB), an artificial protein engineered under the leadership of O.B. Ptitsyn. Various aspects of the amyloid formation of this protein and some methods for controlling this process are investigated in this paper. Four stages of amyloid fibrils formation by this protein from the first non-fibrillar aggregates to mature fibrils and large micron-sized complexes have been described in detail. Dependence of albebetin amyloids formation on external conditions and some mutations also have been described. The introduction of similar point mutations in the two structurally identical α-β-β motifs of ABB lead to different amiloidogenesis kinetics. The inhibitory effect of a disulfide bond and high pH on amyloid fibrils formation, that can be used to control this process, was shown. The results of this work are a good basis for the further design and use of ABB-based amyloid constructs.
format Online
Article
Text
id pubmed-7072675
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70726752020-03-19 The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants Balobanov, Vitalii Chertkova, Rita Egorova, Anna Dolgikh, Dmitry Bychkova, Valentina Kirpichnikov, Mikhail Biomolecules Article Engineering of amyloid structures is one of the new perspective areas of protein engineering. Studying the process of amyloid formation can help find ways to manage it in the interests of medicine and biotechnology. One of the promising candidates for the structural basis of artificial functional amyloid fibrils is albebetin (ABB), an artificial protein engineered under the leadership of O.B. Ptitsyn. Various aspects of the amyloid formation of this protein and some methods for controlling this process are investigated in this paper. Four stages of amyloid fibrils formation by this protein from the first non-fibrillar aggregates to mature fibrils and large micron-sized complexes have been described in detail. Dependence of albebetin amyloids formation on external conditions and some mutations also have been described. The introduction of similar point mutations in the two structurally identical α-β-β motifs of ABB lead to different amiloidogenesis kinetics. The inhibitory effect of a disulfide bond and high pH on amyloid fibrils formation, that can be used to control this process, was shown. The results of this work are a good basis for the further design and use of ABB-based amyloid constructs. MDPI 2020-02-05 /pmc/articles/PMC7072675/ /pubmed/32033353 http://dx.doi.org/10.3390/biom10020241 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Balobanov, Vitalii
Chertkova, Rita
Egorova, Anna
Dolgikh, Dmitry
Bychkova, Valentina
Kirpichnikov, Mikhail
The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants
title The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants
title_full The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants
title_fullStr The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants
title_full_unstemmed The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants
title_short The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants
title_sort kinetics of amyloid fibril formation by de novo protein albebetin and its mutant variants
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072675/
https://www.ncbi.nlm.nih.gov/pubmed/32033353
http://dx.doi.org/10.3390/biom10020241
work_keys_str_mv AT balobanovvitalii thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT chertkovarita thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT egorovaanna thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT dolgikhdmitry thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT bychkovavalentina thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT kirpichnikovmikhail thekineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT balobanovvitalii kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT chertkovarita kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT egorovaanna kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT dolgikhdmitry kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT bychkovavalentina kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants
AT kirpichnikovmikhail kineticsofamyloidfibrilformationbydenovoproteinalbebetinanditsmutantvariants